Product Information

SUCRALFATE 1 GM/10 ML SUSP is a generic product labeled by Torrent Pharmaceuticals Limited, priced at $0.1270 per ML under NDC 13668075442. Its NADAC has been published 57 times since Oct 22, 2025.

FDA first approved this application on Mar 21, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

SUCRALFATE 1 GM/10 ML SUSP

Sucralfate
$0.1270per ML

Strength

1 g/10mL

NDC

13668075442

Classification

Generic

Dosage Form

SUSPENSION

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

SUCRALFATE

Approval Type

Generic (ANDA)

FDA Application

ANDA216726

FDA Approved

3/21/2024

TE Code

AB

On Market Since

9/15/2025

Pharmacological Classes

Aluminum Complex
Organometallic Compounds

Price Statistics

The NADAC for SUCRALFATE 1 GM/10 ML SUSP has been published 57 times since Oct 22, 2025, and over the history we have for it it has risen 2.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1270 per ML
All-time high$0.1270 (Nov 18, 2026)
All-time low$0.1153 (Jul 22, 2026)
52-week high$0.1270
52-week low$0.1153
Median price$0.1221
Average price$0.1218
Largest weekly change+4.9% (Aug 19, 2026)
Weeks tracked57
Tracking sinceOct 22, 2025

Price History

1W

+0.4%

1M

+2.3%

3M

+5.1%

6M

+7.7%

1Y

+4.0%

3Y

N/A

5Y

N/A

All

+2.3%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 11% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of SUCRALFATE 1 GM/10 ML SUSP?

The current National Average Drug Acquisition Cost (NADAC) for SUCRALFATE 1 GM/10 ML SUSP, manufactured by Torrent Pharmaceuticals Limited, is $0.1270 per ML (NDC 13668075442), effective Nov 18, 2026.

How has the price of SUCRALFATE 1 GM/10 ML SUSP changed over time?

Over the history we have for it, the NADAC for SUCRALFATE 1 GM/10 ML SUSP has risen 2.3%. It has been tracked across 57 weekly CMS publications since Oct 22, 2025.

What are the highest and lowest recorded NADAC prices for SUCRALFATE 1 GM/10 ML SUSP?

Since Oct 22, 2025, the NADAC for SUCRALFATE 1 GM/10 ML SUSP has ranged from a low of $0.1153 (Jul 22, 2026) to a high of $0.1270 (Nov 18, 2026), with a median of $0.1221 per ML.

Are there cheaper alternatives to SUCRALFATE 1 GM/10 ML SUSP?

Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SUCRALFATE 1 GM/10 ML SUSP, is $0.1127 per ML — about 11% below SUCRALFATE 1 GM/10 ML SUSP.

Who manufactures SUCRALFATE 1 GM/10 ML SUSP?

SUCRALFATE 1 GM/10 ML SUSP (NDC 13668075442) is labeled by Torrent Pharmaceuticals Limited, and CMS classifies it as a generic product.